Publications

5532 Results

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;AB Cruz;MD Abeloff;WR Jewell;JJ Costanzi;WB Farrar;JP Minton;CK Osborne
Journal / Conference
Classic Papers and Current Comments 1(1):120-128
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;WR Jewell;JJ Costanzi;SJ Altman;JP Minton;RM O'Bryan;CK Osborne
Journal / Conference
Classic Papers and Current Comments 1(1):129-135
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial.

Authors
CP Karakousis;CM Balch;MM Urist;MM Ross;TJ Smith;AA Bartolucci
Journal / Conference
Annals of Surgical Oncology 3(5):446-452
Year
1996
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG Inter-group study.

Authors
KR Rai;B Peterson;L Elias;L Shepherd;J Hines;D Nelson;B Cheson;J Kolitz;CA Schiffer
Journal / Conference
Blood 88:141a(#552)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

Pilot study of cisplatin, doxorubicin, vincristine and etoposide (PAVE) in elderly and frail patients with small cell lung cancer (SCLC).

Authors
V Westeel;N Murray;K Gelmon;M McKenzie;F Wong;J Morris;C Grafton;A Shah;V Tsang;K Goddard;K Murphy;B Sheehan;C. Parsons;R Amy;R Page
Journal / Conference
Proc of the American Society of Clinical Oncology 15(#1125):377
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)

New Chemotherapy/radiation therapy regimens may improve survival for patients with locally advanced unresectable non-small cell lung cancer.

Authors
WJ Curran
Journal / Conference
Working in Oncology - Cope Jan/Feb:10-17
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Ovarian ablation in early breast cancer: overview of the randomised trials

Authors
KS Albain;JJ Crowley;S Green;S Martino;CK Osborne;PM Ravdin
Journal / Conference
The Lancet 348(9036):1189-1196
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Evaluation of low dose alpha-interferon (roferon-A) in patients with advanced renal cell carcinoma: A Southwest Oncology Group study.

Authors
ME Marshall;M Wolf;ED Crawford;IM Thompson;R Flanigan;SP Balcerzak;FJ Meyers
Journal / Conference
Cancer Biotherapy 10(3):205-209
Year
1995
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9012

A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: A Southwest Oncology Group study.

Authors
TD Brown;TR Fleming;PJ Goodman;JS Macdonald;RP Pugh;T O'Rourke
Journal / Conference
Anti-Cancer Drugs 6:219-223
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8611

A multi-center randomized trial of zoladex versus surgical ovariectomy in pre-menopausal patients with receptor positive metastatic brease cancer.

Authors
CW Taylor;S Green;WS Dalton;S Martino;JN Ingle;NJ Robert;DJ Rector;CK Osborne
Journal / Conference
Breast Cancer Research and Treatment 37:37(#19)
Year
1995
Research Committee(s)
Breast
Study Number(s)
SWOG-8692 (INT-0075)